Genedata, a Danaher company and the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced that mAbxience has selected the Genedata Bioprocess (R) enterprise ...

Eppendorf experts discuss regulatory challenges, single-use technologies, and digitalization strategies for scaling from R&D to commercial manufacturing.

Ireland’s biopharmaceutical sector continues to thrive amid key financial incentives, proximity to key markets, and favorable regulatory frameworks.

The continuous manufacturing market offers key growth opportunities in streamlining pharmaceutical production by reducing costs, minimizing downtime, and enhancing product quality. The market is ...

WALTHAM, Mass., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Upstream Bio, Inc. (Nasdaq: UPB), a clinical-stage company developing treatments for inflammatory diseases, with an initial focus on severe ...

Upstream Bio Inc. (NASDAQ: UPB) shares are trading lower during Friday’s session as the stock reacts to recent developments in its clinical trials. Over the last few days, the stock has plunged more ...

Upstream Bio said a Phase 2 clinical trial for its respiratory-disease treatment met its primary endpoint in two dosing regimens, but that a third treatment group didn't see consistent improvements.

Upstream Bio (UPB) lost ~12% in the premarket on Wednesday even after the company said that a mid-stage trial for its experimental asthma therapy, verekitug, succeeded, paving the way for the drug's ...

A phase 2 asthma study of Upstream Bio’s TSLP receptor antagonist has hit its primary endpoint. But, with only the 12-week regimen achieving a Tezspire-like reduction in the annualized asthma ...

– Verekitug provided statistically significant and clinically meaningful reductions in annualized asthma exacerbation rate (AAER) with 100 mg q12 and 400 mg q24 week dosing – – Verekitug also ...

Like the cells they culture, bioreactors come in various shapes, sizes, and specialties. While they share basics like mixing, temperature control, monitoring, and inlets/outlets, the way they were ...